Jim Lee
7Patents
1h-index
8Co-inventors
44Inventor score
Filing activity: Feb 16, 1994 → Dec 8, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5451526A | Determination of oxidant or reductant concentration by the spectrophotometric or visual response in oxidation or reduction of polyaniline | Emerging Cross-Sectional Technologies | 6 | Expired |
| US11602536B2 | Topical treatment of vitiligo by a JAK inhibitor | Human Necessities | 1 | Active |
| US11590137B2 | Ruxolitinib formulation for reduction of itch in atopic dermatitis | Human Necessities | 1 | Active |
| US11510923B2 | Ruxolitinib formulation for reduction of itch in atopic dermatitis | Human Necessities | 1 | Active |
| US12396993B2 | Ruxolitinib formulation for reduction of itch in atopic dermatitis | Human Necessities | 0 | Active |
| US12233067B2 | Topical treatment of vitiligo by a JAK inhibitor | Human Necessities | 0 | Active |
| US11590138B2 | Topical treatment of vitiligo by a jak inhibitor | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.